Keyphrases
Statins
100%
Retrospective Cohort Study
100%
Incident Diabetes
100%
Diabetes Risk
30%
Atorvastatin
20%
Statin Therapy
20%
Statin Use
20%
Diabetogenic
20%
Incident Diabetes Mellitus
20%
Confidence Interval
10%
Hazard Ratio
10%
Beneficial Effects
10%
Fasting Plasma Glucose
10%
Hemoglobin A1c (HbA1c)
10%
Healthcare Professionals
10%
Non-statins
10%
Rosuvastatin
10%
Simvastatin
10%
Lovastatin
10%
Glycated Hemoglobin
10%
MarketScan
10%
Increasing Risk
10%
US FDA
10%
Cardiovascular Prevention
10%
Retrospective Cohort Analysis
10%
History of Diabetes
10%
New-onset Diabetes
10%
Secondary Prevention of Cardiovascular Diseases
10%
Thomson Reuters
10%
Clinical Covariates
10%
Fluvastatin
10%
Demographic Covariates
10%
Commercial Claims
10%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Cohort Study
100%
Diabetes Mellitus
16%
Hemoglobin A1c
8%
Pravastatin
8%
Simvastatin
8%
Rosuvastatin
8%
Mevinolin
8%
Population Study
8%
Atorvastatin
8%
Diabetogenesis
8%
Glycosylated Hemoglobin
8%
Fluindostatin
8%
Cardiovascular Disease
8%